Pallas Pharma Is Profitable and Nearly Out of Cash
Finance
medium30 min0 submissionsStripe
Scenario
Pallas Pharma is a specialty pharma business in US. Last year it reported $218 M of revenue, a gross margin of 31%, and a net profit margin of 12% — its third consecutive profitable year.
The CEO is baffled. The company has $3 M in the bank, has drawn $30 M of its overdraft facility, and has twice delayed supplier payments this quarter.
Balance sheet metrics:
- Days sales outstanding: 81 days
- Days inventory outstanding: 53 days
- Days payables outstanding: 55 days
Revenue grew 30% last year, and the sales team is targeting similar growth again.
Supporting data
liquidity
- cash m
- 3
- overdraft drawn m
- 30
working capital
- days sales outstanding
- 81
- days payables outstanding
- 55
- cash conversion cycle days
- 79
- days inventory outstanding
- 53
income statement
- revenue m
- 218
- net margin pct
- 12
- gross margin pct
- 31
- revenue growth pct
- 30
Your task
Explain to the CEO what is happening and what to do about it. Provide:
- Analysis — why a profitable company is short of cash.
- Risks — what happens if nothing changes.
- Recommendation — the specific actions you would take, in priority order.
Ready to move forward? Up next: Halcyon Bank: Can We Raise Prices 16%?Next question
How you'll be graded
100 points, 60% to pass.
- diagnosis30
- recommendation25
- risk assessment15
- financial analysis30
Hint
Reveal suggested structure
- Cash conversion cycle = DSO + DIO − DPO = 81 + 53 − 55 = 79 days.
- Cash tied up ≈ (CCC ÷ 365) × revenue.
- Growth makes it worse — every extra unit of revenue funds more receivables and inventory before it produces cash.
- Levers, in order of speed: collections, inventory, payment terms.
- Quantify the cash released by improving each lever.